Values First Advisors’s Audentes Therapeutics, Inc BOLD Stock Holding History

Values First Advisors’s Portfolio BOLD Stock Details BOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,791	Closed	-$227K	–	149
2019 Q4	$227K	Buy	+3,791	New	+$142K	0.22%	112

Values First Advisors's BOLD Position: Q1 2020 in Review

Values First Advisors sold out of Audentes Therapeutics, Inc (BOLD) in Q1 2020, closing a stake of 3,791 shares — an estimated $227K sold.

Values First Advisors first reported a position in BOLD in Q4 2019 and held it in 1 quarter. The position peaked at $227K in Q4 2019. 0 funds tracked by Wall St. Rank hold BOLD as of Q1 2020.

Values First Advisors reported no remaining Audentes Therapeutics, Inc position as of Q1 2020 after selling out during the quarter.
Values First Advisors sold 3,791 Audentes Therapeutics, Inc shares in Q1 2020, an estimated $227K.
Values First Advisors first reported a position in Audentes Therapeutics, Inc in Q4 2019 and held it in 1 quarter.
Values First Advisors's Audentes Therapeutics, Inc position peaked at $227K in Q4 2019.
0 funds tracked by Wall St. Rank held Audentes Therapeutics, Inc as of Q1 2020.

Based on Values First Advisors's 13F filing for Q1 2020, filed 9 Jan 2023.